Enhancer of zest homolog 2 (EZH2) expression in well and moderately differentiated pancreatic neuroendocrine tumor (pNET)

被引：2
|
作者：
Marconcini, R. [1 ]
Faviana, P. [2 ]
Campani, D. [2 ]
Galli, L. [1 ]
Antonuzzo, A. [3 ]
Orlandini, C. [1 ]
Falcone, A. [1 ]
Ricci, S. [3 ]
机构：
[1] Univ Azienda Osped Univ S Chiara, UO Oncol Med Univ 2, Pisa, Italy
[2] Azienda Osped Cisanello Pisa, UO Anat Patol, Pisa, Italy
[3] Azienda Osped Univ S Chiara, UO Oncol Med Osped 1, Pisa, Italy
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw369.18
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
433P
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
    Wagener, Nina
    Macher-Goeppinger, Stephan
    Pritsch, Maria
    Huesing, Johannes
    Hoppe-Seyler, Karin
    Schirmacher, Peter
    Pfitzenmaier, Jesco
    Haferkamp, Axel
    Hoppe-Seyler, Felix
    Hohenfellner, Markus
    BMC CANCER, 2010, 10
  • [22] EZH2 Expression in Intestinal Neuroendocrine Tumors
    Faviana, Pinuccia
    Marconcini, Riccardo
    Ricci, Sergio
    Galli, Luca
    Lippolis, Piero
    Farci, Fabiola
    Castagna, Maura
    Boldrini, Laura
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2019, 27 (09) : 689 - 693
  • [23] Enhancer of zeste homolog 2 (EZH2) regulates tumor angiogenesis and predicts recurrence and prognosis of intrahepatic cholangiocarcinoma
    Nakagawa, Shigeki
    Okabe, Hirohisa
    Ouchi, Mayuko
    Tokunaga, Ryuma
    Umezaki, Naoki
    Higashi, Takaaki
    Kaida, Takatoshi
    Arima, Kota
    Kitano, Yuki
    Kuroki, Hideyuki
    Mima, Kosuke
    Nitta, Hidetoshi
    Imai, Katsunori
    Hashimoto, Daisuke
    Yamashita, Yo-ichi
    Chikamoto, Akira
    Baba, Hideo
    HPB, 2018, 20 (10) : 939 - 948
  • [24] Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2)
    Changchien, Yi-Che
    Tatrai, Peter
    Papp, Gergo
    Sapi, Johanna
    Fonyad, Laszlo
    Szendroi, Miklos
    Papai, Zsuzsanna
    Sapi, Zoltan
    JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
  • [25] Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2)
    Yi-Che Changchien
    Péter Tátrai
    Gergő Papp
    Johanna Sápi
    László Fónyad
    Miklós Szendrői
    Zsuzsanna Pápai
    Zoltán Sápi
    Journal of Translational Medicine, 10
  • [26] Value of Enhancer of Zeste Homolog 2 (EZH2) for Determining Prognosis in Colon Cancer
    Gholami, Nassrin
    Sanaat, Zohreh
    Dolatkhah, Roya
    Nikanfar, Alireza
    Esfahani, Ali
    Danandehmehr, Amin
    Akhrjou, Ashraf
    Farassati, Faris
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2020, 14 (03)
  • [27] The methyltransferases enhancer of zeste homolog (EZH) 1 and EZH2 control hepatocyte homeostasis and regeneration
    Bae, Woo Kyun
    Kang, Keunsoo
    Yu, Ji Hoon
    Yoo, Kyung Hyun
    Factor, Valentina M.
    Kaji, Kosuke
    Matter, Matthias
    Thorgeirsson, Snorri
    Hennighausen, Lothar
    FASEB JOURNAL, 2015, 29 (05): : 1653 - 1662
  • [28] Epigenetic dysregulation in well-differentiated pancreatic neuroendocrine tumor (PNET): An immunohistochemistry (IHC) analysis
    Saleh, Zena
    Ghanem, Yazid
    Joshi, Hansa
    Moccia, Mathew C.
    Toma, Helen
    Li, Yahui
    Joneja, Upsana
    Gao, Tao
    Hong, Young
    CANCER RESEARCH, 2024, 84 (06)
  • [29] Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells
    Hibino, S.
    Saito, Y.
    Muramatsu, T.
    Otani, A.
    Kasai, Y.
    Kimura, M.
    Saito, H.
    ONCOGENESIS, 2014, 3 : e104 - e104
  • [30] Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells
    S Hibino
    Y Saito
    T Muramatsu
    A Otani
    Y Kasai
    M Kimura
    H Saito
    Oncogenesis, 2014, 3 : e104 - e104
12345